Navigation Links
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
Date:10/31/2013

in-license drug candidates for their product pipelines and to collaborate with and fund third parties on their drug discovery activities; our ability to out-license our proprietary candidates on favorable terms; and our ability to attract and retain experienced scientists and management. We are providing this information as of October 31, 2013. We undertake no duty to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements or of anticipated or unanticipated events that alter any assumptions underlying such statements.

CONTACT:

Tricia Haugeto (303) 386-1193 thaugeto@arraybiopharma.com Array BioPharma Inc.Condensed Statements of Operations(Unaudited)(in thousands, except per share amounts)Three Months Ended
September 30,20132012RevenueLicense and milestone revenue$
,065$
2,476Collaboration revenue4,1633,357Total revenue14,22815,833Operating expensesCost of partnered programs10,6586,539Research and development for proprietaryprograms11,70413,534General and administrative5,1794,780Total operating expenses27,54124,853Loss from operations(13,313)(9,020)Other income (expense)Interest income1611Interest expense(2,383)(2,759)Total other expense, net(2,367)(2,748)Net loss$
(15,680)$
(11,768)Weighted average shares outstanding - basic and diluted117,50992,606Net loss per share - basic and diluted$
(0.13)$
(0.13)Summary Balance Sheet Data(in thousands)September 30, 2013June 30, 2013Cash, cash equivalents and marketable securities$
23,721$
8,706Property, plant and equipment, gross$
88,734$
88,537Working capital$
82,290$
70,732Total assets$
52,645$
35,988Long-term debt, net$
,203$
99,021Stockholders' deficit$
(13,162)$
(21,909) 


'/>"/>
SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  ViaCyte, Inc., a ... therapy for the treatment of diabetes in clinical trials, today announced ... called STEP ONE, or S afety, T olerability, and ... One Diabetes.  The new site, which is the first ... of Alberta Hospitals in Edmonton , Alberta.  ...
(Date:7/29/2015)... -- Fifty groups representing 500,000 patients, doctors, and researchers will ... AllTrials campaign in the US. The global campaign calls ... be registered and the results from it reported. ... explains: "Patients want the treatments that are best for ... Unfortunately, we now know that around half of all ...
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ... "Global Wound Care Markets (Twelve Country Analysis: Germany, ... China, India, Brazil, Australia, South Korea)" report ... provides a competitive market summary. The wound care ... offerings and product maturity. Several of the products ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3Global Wound Care Markets 2015 2
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement ... in women-led, growth companies and is led by a group of experienced investors, has ... and voted with their dollars to be a part of the fund. The ...
(Date:7/29/2015)... , ... July 29, 2015 , ... CanAm Enterprises, LLC ... USCIS over the past month! I-829 approvals have been granted to investors in four ... Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center ...
(Date:7/29/2015)... Angeles, CA (PRWEB) , ... July 29, 2015 ... ... to Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., ... pro bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We ...
(Date:7/29/2015)... ... , ... Employee Fiduciary, LLC announces the launch of its new, online Financial ... plans administered, years in business, and credentials of all Employee Fiduciary financial advisor ... Employee Fiduciary. A search can be done by zip code so a plan sponsor ...
(Date:7/29/2015)... ... 2015 , ... TransFlip is an all new dynamic transition pack for FCPX, ... these transitions are easy to apply and modify for any skill-level user. TransFlip includes ... preset styles, kinetic flipping panel animations are just a few clicks away. , TransFlip ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2
... Sciences (AIIMS) Director Dr. P. Venugopal won a reprieve ... resolution of the Institute's Governing Body recommending his sacking.// ... the termination of Venugopal's services, is stayed and the ... recommendation,' Justice Anil Kumar said in his order. ...
... A 25-year-old youth in a West Bengal hospital is ... medical miracle that is attracting hundreds of curious visitors//. ... km north of Kolkata in Nadia district, has no ... Sambhu Roy, who suffered severe burns while almost getting ...
... to introduce new legislation to regulate doctors, due to be ... seeking Government approval in order to publish heads of bill ... that a new Medical Practitioners Bill can be published later ... Act have been promised and postponed for many years, it ...
... are attempting to short circuit the progression of Parkinson's ... Parkinson's patients earlier on in the course of their ... study is the possibility that if deep brain stimulation ... progression of the disease, hopefully slowing its advance,' said ...
... skin’s aging process, but Igor Sokolov, a Physics professor ... look as old as you are//. ,Scientists ... lose elasticity with aging, but until recently they didn’t ... magazine recently reported on research conducted by Sokolov and ...
... and Ganesh Shanker Vidyarathi Medical College today took out ... as Director of the premier All-India Institute of Medical ... that said Venugopal was being made a "scapegoat", the ... premises to Moti Jheel area raising slogans against Union ...
Cached Medicine News:Health News:Man Holds Own Skull in Bengal Medical Miracle 2Health News:Researchers Try Early Surgical Intervention to Treat Parkinson's Symptoms 2Health News:Researchers Try Early Surgical Intervention to Treat Parkinson's Symptoms 3Health News:"Anti Aging" Skin Cream Developed at Clarkson University 2
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Inquire...
... The Perfect Single Vac ... one 96-well plate in 30 ... with an "open/closed" switch and ... for easy operation. contains vacuum ...
... has been designed for use with Bioneer's ... can handle 96 samples (Plasmid DNA, Genomic ... and purification. While conventional kits use centrifugal ... BioVac 96 Vacuum Manifold uses vacuum pressure ...
Medicine Products: